Multidrug resistance in pediatric oncology

Investigational New Drugs

Volumn 14, Issue 1, 1996, Pages 55-67

  Kuttesch Jr , John F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Children; Drug resistance; Ewing's sarcoma; Leukemia; Neuroblastoma; Osteosarcoma; P glycoprotein; Retinoblastoma; Rhabdomyosarcoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; IFOSFAMIDE; MELPHALAN; MULTIDRUG RESISTANCE PROTEIN; VINCRISTINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; EWING SARCOMA; HUMAN; LEUKEMIA; MOUSE; MULTIDRUG RESISTANCE; NEUROBLASTOMA; NONHUMAN; OSTEOSARCOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; RHABDOMYOSARCOMA; SCHOOL CHILD; SOLID TUMOR;

EID: 0029789802     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00173683     Document Type: Review

References (24)

1. Biedler JL, Reihm H: Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic and cytogenetic studies. Cancer Res 30:1174-1184, 1970
2. Ling V, Thompson LH: Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Phsyiol 83:103-116, 1974
3. Juliano RL, Long V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 435:152-162, 1976
4. Houghton PJ: Chapter 5. Modulation of p-Glycoprotein-mediated multidrug resistance. In: Tew KD, Houghton PJ, Houghton JA (eds): Preclinical and Clinical Modulation of Anticancer Drugs. CRC Press, Boca Raton, Florida, 1993, pp 125-196
5. Juranka PF, Zastawny RL, Ling V: P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB J 3:2583-2592, 1989
6. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654, 1992
7. Scheper RJ, Broxterman HJ, Scheffer GL, Kaaijk P, Dalton WS, van Heijningen THM, van Kalken CK, Slovak ML, de Vries EG, Van der Valk P, Meijer C, J.L.M., Pinedo HM: Overexpression of MR 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 53:1475-1479, 1993
8. Beck WT, Danks MK: Mechanisms of resistance to drugs that inhibit DNA topoisomerases. Semin Cancer Biol 2:235-244, 1991
9. Danks M, Yalowich J, Beck W: A typical multiple drug resistance in a human leukemic cell lineselected for resistance to teniposide (VM-26). Cancer Res 47:1297-1302, 1987
10. Kartner N, Evernden-Poreile D, Bradley G, Ling V: Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonar antibodies. Nature 316:820, 1985
11. Dalton WS, Grogan TM, Rybski JA, Scheper R, Richter L, Kailev J, Broxterman HJ, Pinedo HM, Salmon SE: Immunohistochemical detection and quantification of P-glycoprotein in multiple drug-resistant human myeloma cells: Association with level of drug resistance and drug accumulation. Blood 73:747-752, 1989
12. Horton JK, Houghton JA, Houghton PJ: Expression of multidrug resistance gene (MDR1) in human tumor xenografts sensitive and resistant to natural products: failure to predict chemosensitivity. J Cell Pharmacol 2:208-216, 1991
13. Shen D, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S, Pastan I, Gottesman MM: Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vin-blastine show changes in expression of specific proteins. J Biol Chem 261:7762-7770, 1986
14. Ueda K, Cardarelli C, Gottesman MM, Pastan I: Expres-sion of a full length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84:3004-3008, 1987
15. Chan HSL, Thorner P, Haddad G, Ling V: Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8:689-704, 1990
16. Campos L, Guyotat D, Archimbaud E, Caimara-Orioi P, Tsuruo T, Troncy J, Treme D, Fiere D: Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79:473-476, 1992
17. Leuschner I, Schmidt D, Hoffmann H, Dietel M, Harms D: Expression of p-glycoprotein in soft tissue tumors of childhood correlation to treatment response. J Cancer Res Clin Oncol 117:510-514, 1993 (abstract)
18. Favrot M, Combaret V, Goillot E, Wagner JP, Bouffet E, Mazingue F, Thyss A, Bordigoni P, Delsol G, Bailly C, Fontaniere B, Philip T: Expression of p-glycoprotein restricted to normal cells in neuroblastoma biopsies. Br J Cancer 64:233-238, 1991
19. Chan HSL, Haddad G, Thorner PS, DeBoer G, Lin YP, Ondrusek N, Yeger H, Ling V: P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325:1608-1614, 1991
20. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-94, 1991
21. Dalton WS, Grogan TM, Meltzer P, Scheper R, Durie BGM, Taylor C, Miller T, Salmon S: Drug-Resistance in Multiple Myeloma and Non-hodgkin's Lymphoma: Detection of P-Glycoprotein and Potential Circumvention by Addition of Verapamil to Chemotherapy. J Clin Oncol 7:415-424, 1989
22. Garberoglio C, Dudas M, Casper ES, Bertino J, Cordon-Cardo C: Expression of P-glycoprotein in normal muscle cells and myogenic tumors. Arch Pathol lab Med 116: 1055-1061, 1992
23. Schlaifer D, Laurent G, Chittal S, Tsuruo T, Soues S, Muller C, Charcosset JY, Alard C, Brousset P, Mazerrolles C, Delsol G: Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers. Br J Cancer 62:177-182, 1990
24. Hegewisch-Becker S, Fliegner M, Tsuruo T, Zander A, Zeller W, Hossfeld DK: P-glycoprotein expression in normal and reactive bone marrows. Br J Cancer 67:430-435, 1993